Dr. Panayotatos has received degrees from the University of Athens (B.Sc.), Ohio University (M.Sc.) and Loyola University of Chicago (Ph.D.) and conducted post-doctoral work at the University of Wisconsin.

Dr. Nikos Panayotatos has over 30 years of academic, industrial and consulting experience in R&D of biologics. His work is described in 43 major
publications, 17 US patents and many patents worldwide. He speaks English, Greek and French.

He has held senior positions at Biogen, Michigan Biotechnology Institute/Michigan State University and Regeneron Pharmaceuticals. Dr. Panayotatos has planned and directed the development of many human recombinant proteins as therapeutics. He has invented gene expression systems, protein production technology, rationally designed proteins and targeted drug delivery methods. He has discovered the T7 late promoter, cruciform DNA structures in vitro and in vivo and created hybrid enzymes targeting unusual DNA structures. As a consultant, Dr. Panayotatos has advised clients on the development of recombinant proteins, including mAbs and small peptides; led the efforts of a start-up company as interim CSO; provided technical expertise on major cases of patent litigation that won his clients settlements of over $600 million; and, advised clients on technology and intellectual property assessment.